Public Reporting A2024

As required by CMS, the information on this webpage contains our Public Reporting information

ACO Name and Location:

Accountable Care Organization of Pennsylvania, LLC (Delaware Valley ACO)
Previous Names: N/A
259 North Radnor Chester Road
Suite 290
Radnor, Pennsylvania 19087

ACO Primary Contact

Primary Contact Name Jeanette Flood
Primary Contact Phone Number 610-225-6210
Primary Contact Email Address floodj@dvaco.org

Organizational Information

ACO Participants:

ACO Participants ACO Participant in Joint Venture (Enter Y or N)
Abington Memorial Hospital (Abington, Abington-Lansdale and Employed Physicians) N
ABS Medicine LLC (Simpson Allergy & Asthma) N
Aria Health N
Aria Health Orthopaedics N
Aria Health Physician Services N
Associates in Pastic Surgery, Inc N
Balmont Family Practice N
Barry Burkhardt N
Broker, Cramer & Swanson ENT, PC (ENT and Allergy Specialists) N
CSB Medicine, LLC (Narberth Allergy and Asthma) N
Daniel C. Lazowick, D.O., LLC N
Deebeanne M Tavani DO PhD PC N
Delaware Valley I.D. Associates, P.C. N
Devon Family Practice LLP N
Edward Stankiewicz N
Endeavor Health LLC N
Geoffrey W. Temple Family Medical Associates, P.C. N
Gerard Miller N
Great Valley Medical Associates PC N
Great Valley Neurological Associates LLC N
Jefferson Medical Care, PC N
Jefferson University Physicians N
Jefferson University Physicians of New Jersey PC N
Jefferson University Radiology Associates LLC N
Jon Yardney, M.D. LLC N
Joseph LaBricciosa DO PC N
Lawrence I Katin MD PC N
Lower Merion Family Medicine PC N
Lower Merion Rehabilitation N
Magee Rehabilitation Hospital N
Main Line Allergy, L.L.P. N
Main Line Emergency Med Associates LLC N
Main Line Health HomeCare and Hospice N
Main Line Health Imaging, LP N
Main Line HealthCare N
Main Line Hospitals, Inc. (Bryn Mawr Hospital, Bryn Mawr Rehabilitation Hospital, Lankenau Medical Center, Mirmont Treatment Center, Paoli Hospital, Riddle Hospital) Y
Main Line Institute of Plastic Surgery Inc N
Main Line Pathology Associates, PC N
Main Line Radiation Oncology PC N
Mazzoni Center N
Medical Associates of the Main Line, PC N
Methodist Associates in Healthcare, Inc. N
Methodist Associates in Healthcare Of New Jersey, P.C. N
Mukesh Patel N
Paoli Family Medicine N
Peter Christie N
Philadelphia Family Medicine Assoc P.C. N
Philadelphia Health Associates – Adult Medicine, P.C. N
Pulmonology Associates Inc N
Radiology Associates of the Main Line PC N
Radnor Family Practice Professional Limited Liability Company N
Rehabilitation Associates of the Main Line, P.C. N
Rheumatology Medical Specialists PC N
Riddle Memorial Hospital (a Main Line Health Hospital) Y
Ross Podell, M.D., P.C. N
Roy M Lerman MD PC (Main Line Spine) N
Segal Aaronson Pulmonary Associates PC (Acquired by Jefferson University Physicians) N
Smith Medicine, PC N
Suburban Endocrinology Associates, PC N
Thomas Jefferson University Hospitals, Inc. (Jefferson Hospital for Neuroscience, Methodist Hospital, Thomas Jefferson University Hospital) Y
United Anesthesia Services PC N
William Greer, M.D., P.C. N
William J. Lewis, M.D., P.C. (Main Line Ear, Nose and Throat/Head and Neck Surgery) N
William R. Schetman, M.D., LLC N

ACO Governing Body:

Member Member’s Voting Power– Expressed as a percentage or number Membership Type ACO Participant Legal Business Name/DBA, if Applicable
Last Name First Name Title/Position
Gleason, M.D. Johnathan Co-Chair 1 ACO Participant Representative Thomas Jefferson University Hospitals, Inc.
Mankin, M.D. Eric Co-Chair 1 ACO Participant Representative Main Line Health Hospitals, Inc.
Behan, M.D. Katherine 1 ACO Participant Representative Thomas Jefferson University Hospitals, Inc.
Gorman Kirk 1 Medicare Beneficiary Representative N/A
Greer, M.D. William 1 ACO Participant Representative William Greer, M.D., P.C.
Angelo, M.D. Mark 1 Other: ACO Acting President & Chief Executive Officer N/A
Stallkamp, M.D. Jonathan 1 ACO Participant Representative Main Line Hospitals Inc.
Sweigard, M.D. Keith 1 ACO Participant Representative Abington Memorial Hospital

Key ACO Clinical and Administrative Leadership:

ACO Executive (Acting President & CEO) Mark Angelo, M.D., MHA, FACP
Medical Director (Chief Clinical Officer)Mark Angelo, M.D., MHA, FACP Mark Angelo, M.D., MHA, FACP
Compliance Officer Christopher Jackson
Quality Assurance/Improvement Officer (Director, Quality Improvement) Virginia Bodycot, BSN, RN

Associated Committees and Committee Leadership:

Committee Name Committee Leader Name and Position
Audit and Finance Committee Michael J. Buongiorno (Chair)
Clinical Integration Committee Katherine Behan, M.D. (Co-Chair)
Eric Mankin, MD (Co-Chair)

Types of ACO Participants, or Combinations of Participants, That Formed the ACO:

  • ACO professionals in a group practice arrangement
  • Hospital employing ACO professionals
  • Partnerships or joint venture arrangements between hospitals and ACO professionals

Shared Savings and Losses

Amount of Shared Savings/Losses

  • Third Agreement Period
    • Performance Year 2020, $0
  • Second Agreement Period
    • Performance Year 2019, $0
    • Performance Year 2018, $0
    • Performance Year 2017, $0
  • First Agreement Period
    • Performance Year 2016, $0
    • Performance Year 2015, $0
    • Performance Year 2014, $6,567,267

Shared Savings Distribution

  • Third Agreement Period
    • Performance Year 2020
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
  • Second Agreement Period
    • Performance Year 2019
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
    • Performance Year 2018
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
    • Performance Year 2017
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
  • First Agreement Period
    • Performance Year 2016
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
    • Performance Year 2015
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
    • Performance Year 2014
      • Proportion invested in infrastructure: 15%
      • Proportion invested in redesigned care processes/resources: 15%
      • Proportion of distribution to ACO participants: 70%

Quality Performance Results

2020 Quality Performance Results:

ACO Quality Measure Number Measure Name Rate ACO Mean
ACO-1 CAHPS: Getting Timely Care, Appointments, and Information N/A N/A
ACO-2 CAHPS: How Well Your Providers Communicate N/A N/A
ACO-3 CAHPS: Patients’ Rating of Provider N/A N/A
ACO-4 CAHPS: Access to Specialists N/A N/A
ACO-5 CAHPS: Health Promotion and Education N/A N/A
ACO-6 CAHPS: Shared Decision Making N/A N/A
ACO-7 CAHPS: Health Status/Functional Status N/A N/A
ACO-34 CAHPS: Stewardship of Patient Resources N/A N/A
ACO-45 CAHPS: Courteous and Helpful Office Staff N/A N/A
ACO-46 CAHPS: Care Coordination N/A N/A
ACO-8 Risk Standardized, All Condition Readmission N/A N/A
ACO-38 All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions N/A N/A
ACO-43 Ambulatory Sensitive Condition Acute Composite (AHRQ* Prevention Quality Indicator (PQI #91)) 0.94 0.95
ACO-13 Falls: Screening for Future Fall Risk 91.19 84.97
ACO-14 Preventive Care and Screening: Influenza Immunization 85.56 76.03
ACO-17 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention 68.75 81.67
ACO-18 Preventive Care and Screening: Screening for Depression and Follow-up Plan 63.79 71.46
ACO-19 Colorectal Cancer Screening 71.43 72.59
ACO-20 Breast Cancer Screening 80.24 74.05
ACO-42 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease 81.74 83.37
ACO-27 Diabetes: Hemoglobin A1c Poor Control (>9%) 13.10 14.70
ACO-28 Controlling High Blood Pressure 71.05 72.87

For Previous Years’ Financial and Quality Performance Results, please visit data.cms.gov.

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low sample size. The Centers for Medicare & Medicaid Services (CMS) also waived the requirement for ACOs to field a CAHPS for ACOs survey for PY 2020 through the Physician Fee Schedule Final Rule for Calendar Year 2021. Additionally, CMS reverted ACO-8 Risk-Standardized, All Condition Readmission and ACO-38 Risk-Standardized Acute Admission Rates for Patients with Multiple Chronic Conditions to pay-for-reporting, given the impact of the coronavirus disease 2019 (COVID-19) public health emergency (PHE) on these measures.

Contact Information

Address PO Box 356, Villanova, PA 19085
Phone 610-225-6295
Toll Free Number 855-761-9345
TTY# 610-225-6275
Compliance Line 610-225-6211
Email dvacomail@dvaco.org
Business Hours 9-5pm